WELCOME TO SANTA MONICA CLINICAL TRIALS
Santa Monica Clinical Trials is a private clinical research site located in Los Angeles, California. Our Investigators have over 20 years of experience and are engaged in numerous phase II-IV clinical research trials, including drug and medical device studies. Participation does not require proof of medical insurance. All trials are conducted under FDA guidance and regulations.
If you or a loved one suffers from one of these disorders, take the next step and contact a member of our study team today! No medical insurance needed. Compensation for time & travel may be available.
Motion sickness is a common condition affecting about 30% of the population. Common symptoms of motion sickness include nausea, vomiting, stomach awareness, pallor, headache, sweating, dizziness, a sensation of warmth and drowsiness. The purpose of the study is to evaluate the effectiveness of an investigational drug on symptoms associated with motion sickness and to assess the safety of the investigational drug.
SLEEP DISTURBANCES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that is associated with persistent deficits in social communication, restricted/repetitive behaviors, among other symptoms. Sleep disruption in individuals with ASD is higher than in healthy controls with a documented prevalence of up to 80%. The purpose of this study is to evaluate the effectiveness and safety of the study medication on sleep in individuals with autism spectrum disorder.
DELAYED SLEEP-WAKE PHASE DISORDER
Delayed sleep–wake phase disorder (DSWPD) is a chronic dysregulation of a person's circadian rhythm (biological clock), compared to those of the general population and societal norms. People with DSWPD generally fall asleep some hours after midnight and have difficulty waking up in the morning. However, they find it very difficult to wake up in time for a typical school or work day. If they are allowed to follow their own schedules, e.g. sleeping from 4:00 am to 1:00 pm, their sleep is improved and they may not experience excessive daytime sleepiness. The purpose of this study is to evaluate the efficacy and safety of an investigational medication compared to placebo for this condition.
Narcolepsy is a neurological disorder that affects an individual's control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. The purpose of this study is to learn how well the study drug works and how safe the study drug is compared with a placebo in treating narcolepsy with cataplexy or narcolepsy without cataplexy.
Obstructive Sleep Apnea (OSA) is a common and serious sleep disorder in which breathing is repeatedly interrupted during sleep. OSA occurs when the airway collapses as you breathe in. This can cause breathing to be paused from several seconds to over a minute.
While many people use continuous positive airway pressure (CPAP) machines to manage their OSA, these systems can be cumbersome and awkward for some. The VicTor study involves an investigational oral medication for people who have OSA. The investigational medication will be taken daily at bedtime.